Charles River Laboratories International (CRL) Invested Capital: 2009-2025
Historic Invested Capital for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $3.4 billion.
- Charles River Laboratories International's Invested Capital fell 9.95% to $3.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 billion, marking a year-over-year decrease of 9.95%. This contributed to the annual value of $3.5 billion for FY2024, which is 3.76% down from last year.
- According to the latest figures from Q3 2025, Charles River Laboratories International's Invested Capital is $3.4 billion, which was up 1.51% from $3.4 billion recorded in Q2 2025.
- In the past 5 years, Charles River Laboratories International's Invested Capital registered a high of $3.8 billion during Q3 2024, and its lowest value of $2.2 billion during Q1 2021.
- Over the past 3 years, Charles River Laboratories International's median Invested Capital value was $3.4 billion (recorded in 2025), while the average stood at $3.4 billion.
- Its Invested Capital has fluctuated over the past 5 years, first climbed by 28.64% in 2021, then declined by 12.23% in 2025.
- Charles River Laboratories International's Invested Capital (Quarterly) stood at $2.5 billion in 2021, then rose by 17.28% to $3.0 billion in 2022, then grew by 20.84% to $3.6 billion in 2023, then fell by 3.76% to $3.5 billion in 2024, then dropped by 9.95% to $3.4 billion in 2025.
- Its last three reported values are $3.4 billion in Q3 2025, $3.4 billion for Q2 2025, and $3.2 billion during Q1 2025.